Stemline amends IPO

Stemline Therapeutics Inc., New York, N.Y. Business: Cancer Date announced: 7/19/12 Type: IPO To be raised: Up to $52.3 million Shares: 3.5 million Price: $11-$13 Underwriters: Oppenheimer; RBC Capita...